Prevalence of symptomatic axial osteoarthritis phenotypes in Spain and associated socio-demographic, anthropometric, and lifestyle variables
Por:
Silva-Diaz, M, Blanco, F, Vila, V, Seoane-Mato, D, Perez-Ruiz, F, Juan-Mas, A, Pego-Reigosa, J, Narvaez, J, Quilis N, Cortes, R, Perez, A, Canales, D, Gaya, T, Ferrer, C, Prado-Galbarro, F, Sanchez-Piedra, C, Diaz-Gonzalez, F, Bustabad-Reyes, S and Working Grp Proyecto EPISER2016
Ahead of Print:
1 nov 2021
Resumen:
Objective Axial osteoarthritis (OA) is a common cause of back and neck pain, however, few studies have examined its prevalence. The aim was to estimate the prevalence and the characteristics of symptomatic axial OA in Spain. Methods EPISER2016 is a cross-sectional multicenter population-based study of people aged 40 years or older. Subjects were randomly selected using multistage stratified cluster sampling. Participants were contacted by telephone to complete rheumatic disease screening questionnaires. Two phenotypes were analyzed, patients with Non-exclusive axial OA (NEA-OA) and Exclusive axial OA (EA-OA). To calculate the prevalence and its 95% confidence interval (CI), the sample design was considered and weighting was calculated according to age, sex and geographic origin. Results Prevalence of NEA-OA by clinical or clinical-radiographic criteria was 19.17% (95% CI: 17.82-20.59). The frequency of NEA-OA increased with age (being 3.6 times more likely in patients aged 80 s or more than in those between 40 and 49 years) and body mass index. It was significantly more frequent in women, as well as in the center of Spain. It was less frequent in those with a higher level of education. Lumbar OA was more frequent than cervical OA. This difference grew with increasing age and was not associated with gender. It was also greater in overweight and obese subjects. Conclusions This is the first study on the prevalence of axial OA phenotypes in Europe describing the associated socio-demographic, anthropometric, and lifestyle variables.
Filiaciones:
Silva-Diaz, M:
Univ A Coruna, Complexo Hosp Univ A Coruna CHUAC, Inst Invest Biomed Coruna INIBIC, Unidad Invest Clin,Grp Invest Reumatol GIR,Sergas, La Coruna, Spain
Blanco, F:
Univ A Coruna, Complexo Hosp Univ A Coruna CHUAC, Inst Invest Biomed Coruna INIBIC, Unidad Invest Clin,Grp Invest Reumatol GIR,Sergas, La Coruna, Spain
Univ Coruna UDC, Grp Invest Reumatol & Salud GIR S, Dept Fisioterapia Med & Ciencias Biomed, Fac Fisioterapia, Campus Oza, La Coruna, Spain
Vila, V:
Hosp Comarcal Monforte de Lemos, Rheumatol Unit, Lugo, Spain
Seoane-Mato, D:
Spanish Soc Rheumatol, Res Unit, Madrid, Spain
Perez-Ruiz, F:
Hosp Univ Cruces, Rheumatol Dept, Baracaldo, Vizcaya, Spain
Juan-Mas, A:
Hosp Son LLatzer, Rheumatol Dept, Palma De Mallorca, Baleares, Spain
Pego-Reigosa, J:
Inst Invest Sanitaria Galicia Sur IISGS, Complejo Hosp Univ Vigo, Grp IRIDIS, Rheumatol Dept, Vigo, Pontevedra, Spain
Narvaez, J:
Hosp Univ Bellvitge, Rheumatol Dept, Barcelona, Spain
Quilis N:
Hosp Gen Univ Elda, Rheumatol Dept, Alicante, Spain
:
Hosp Gen Ontinyent, Rheumatol Dept, Valencia, Spain
Perez, A:
Complejo Hosp Jaen, Rheumatol Dept, Jaen, Spain
Canales, D:
Hosp Barbastro, Rheumatol Dept, Barbastro, Huesca, Spain
Gaya, T:
Hosp Comarcal Inca, Rheumatol Dept, Inca, Baleares, Spain
Ferrer, C:
Hosp Comarcal Inca, Rheumatol Dept, Inca, Baleares, Spain
Prado-Galbarro, F:
Metropolitan Autonomous Univ, Biol Syst Dept, Orphan Drug Lab, Mexico City, DF, Mexico
Sanchez-Piedra, C:
Spanish Soc Rheumatol, Res Unit, Madrid, Spain
Diaz-Gonzalez, F:
Univ La Laguna, Dept Internal Med Dermatol & Psyquiatry, San Cristobal la Laguna, Santa Cruz De T, Spain
Hosp Univ Canarias, Rheumatol Dept, San Cristobal la Laguna, Santa Cruz De T, Spain
Bustabad-Reyes, S:
Hosp Univ Canarias, Rheumatol Dept, San Cristobal la Laguna, Santa Cruz De T, Spain
hybrid
|